Once again, there are awards for both individual receptionists and reception teams
The winners will receive trophies and Amazon vouchers.
Emma Coole, Account Manager for the South West of the UK at KRKA UK said: "Reception teams are the glue that holds a busy practice together.
"They’re juggling phone calls, managing appointments, supporting worried pet owners at the front desk - and doing it all with empathy and professionalism.
"I regularly see and hear first-hand how much the wider vet practice depends on their calm, capable presence.
"These awards are a chance to recognise the people who make that happen every single day.”
Practices are encouraged to nominate receptionists or teams who make a real difference – whether through kindness, a cool head under pressure or simply keeping everything running smoothly.
Nominations are now open and will close on Friday 26th September 2025.
Winners and runners-up will be announced on Wednesday 1st October 2025.
To submit a nomination or learn more about the awards, visit https://bit.ly/receptionist-team-hero-awards-2025
Veterinary practices are signing up fast for the opportunity to take part in Pet Smile Month in September 2010, according to organisers.
Participating practices carry out free dental checks in September as part of a nationwide campaign to promote dental health in pets.
Pet Smile Month founder, veterinary surgeon Bob Partridge said: 'Pet Smile Month is all about relieving pain and suffering in pets and educating owners on the importance of dental care for pets. It also highlights the caring nature of the profession and provides practices with an opportunity to promote the range of services it offers.'
Registered practices will receive information leaflets to give to clients, and an educational poster - illustrating the problems of dental disease and encouraging clients to seek dental care.
For Pet Smile Month 2010, as well as the Pet Smile Art Competition (with prizes for young clients), Kruuse has offered the iM3 42-12 dental scaler as a prize for the best waiting room Pet Smile Month display, together with runner-up prizes.
Pet Smile Month could not exist without the long-standing commitment of Petosan, Genitrix, CEVA, Kruuse, NVS, Centaur, Dunlops, Veterinary Surgeons' Supply Company and IGP UK Ltd.
To find a participating local veterinary practice, owners can use the 'Find-a-PSM-Vet' button at http://www.petsmile.org/. There is also a dedicated vet area on the website.
London's Savile Row was turned into a sheep field today, to highlight The Campaign For Wool; a coalition of industry groups convened by HRH The Prince of Wales to educate consumers about the benefits of wool.
As the sheep grazed, the Row's famous tailoring houses held events where the public could find out more about the natural, sustainable qualities of wool.
Douglas Cordeaux, Managing Director of West Country woollen mill Fox Brothers, one of the organisations behind the promotion said: "We have a collective responsibility to champion this versatile, sustainable and natural fibre, the production of which involves far lower carbon emissions than man‐made alternatives. We need to support farmers who are the custodians of our rural landscape and truly value the qualities of this wonderful resource, which is used to weave the finest luxury cloth you can buy."
John Thorley of the Campaign for Wool said: 'I'd like to see wool re-established as a fibre of consequence where workers get paid properly and people recognise that this animal is useful to the farming sector in a multitude of ways.'
For more information, see www.campaignforwool.org and www.savilerowfieldday.com
The RCVS has launched its new Fellowship scheme and is now accepting applications from veterinary surgeons who have made a meritorious contribution to their particular field.
The new Fellowship scheme was launched with three routes to membership: meritorious contributions to knowledge; meritorious contributions to clinical practice; and meritorious contributions to the profession.
The changes were approved by RCVS Council at its June 2015 meeting, following a public consultation on how the Fellowship could be developed to move it away from being an examination-based award, to becoming a learned society.
Dr Bradley Viner, President of the RCVS, said: "I am very proud to announce the launch of the new Fellowship scheme and I hope that, as a learned body, the Fellowship will help advance and develop clinical and professional standards by sharing their knowledge and expertise with the profession.
"The move from being an examinations-based award to the three new paths to entry is a significant development as it will widen the reach of the Fellowship, particularly to those who are working in clinical practice.
"I would strongly encourage all those who feel they have made a meritorious contribution to any of these three areas to apply as I am very hopeful we will be able to award our first group of new Fellowships at RCVS Day on Friday 15 July."
The criteria for achieving Fellowship includes sustained contribution to scholarship; producing a body of creative work that has been disseminated to others; indisputable advancement of their subject; providing leadership to the profession; and, advancement of the public understanding of the profession.
Each application will be assessed by a Credentials Panel to see if it meets the proposed criteria. Applications approved by the Panel will then be put to the Fellowship Board, which will meet once a year to consider the overall list of proposed applications.
The closing date for initial applications is Wednesday 11 May. Application forms for the three different routes to Fellowship, as well as further details about criteria and a list of relevant doctorate programmes, can be found at www.rcvs.org.uk/fellowship
All current Fellows, including Honorary Fellows, will retain their FRCVS/HonFRCVS status.
The Practice Standards Scheme was launched in 2005 and then relaunched in 2015 to better recognise and reward how practices use their resources to create a positive outcome for patients and clients.
The modules and awards for all species groups (small animals, farm animal, and equine) have now been updated and a summary of the changes can be found at the end of each set of the respective modules.
Pam Mosedale, Lead Assessor, said: "These updates are part of our continuous efforts to ensure we have a flexible PSS, one that can respond to feedback and constantly reflect the realities of everyday practice.
"We would encourage all PSS-accredited practices to familiarise themselves with the updated modules, especially if they have an accreditation or awards assessment in the near future."
To view the updates, visit: http://www.rcvs.org.uk/practice-standards-scheme/ and download the appropriate 'related document' (v1.2)
The new gel is made from natural resin combined with zinc salts which NoBACZ says provides both physical and microbial protection.
NoBACZ says that unlike water-based gels and sprays, including aerosols, that dilute in water and wash away, Ambugreen’s natural resin is hydrophobic which improves contact times between the product and the skin in wet conditions.
The gel barrier can be used anywhere on the skin where a bandage or spray has conventionally been used for protection, such as the management of lameness and to protect sore skin in livestock and to manage udder cleft issues in cows.
Ambugreen also offers fly protection and is suitable for use on all livestock, including copper-sensitive sheep breeds.
Dr David Charles, veterinary surgeon and international business development manager at NoBACZ Healthcare, said: “Ambugreen provides farmers with next generation protection for their livestock and is the perfect antibiotic-free tool to help protect wounds from bacterial ingress from the environment; enhancing the health and welfare of animals whilst preventing economic losses.”
Laura Donovan, veterinary surgeon and partner at Nantwich Farm Vets, adds: “We were lucky enough to have trialled Ambugreen with our dairy clients who have successfully used the gel barrier for udder cleft dermatitis and were very pleased with the results.”
www.nobacz.com
Vetoquinol has announced that Epiphen® Solution, the phenobarbital anti-epileptic treatment for dogs, is now back in stock following a manufacturing issue that has been successfully resolved.
The company says the solution now completes the Epiphen® range to offer convenient dosing for all weights of animal as part of its overall epilepsy management package.
To order, please contact your wholesaler or Vetoquinol Territory Manager.
A new publication into the benefits of spironolactone (Prilactone - CEVA Animal Health) has supported its use as part of first-line therapy for the treatment of dogs with congestive heart failure caused by mitral heart disease, according to CEVA.
The double-blind placebo-controlled study1 involved 212 dogs on either spironolactone or a placebo, in addition to conventional therapy including an ACE inhibitor and furosemide. It revealed that over a 15 month period 25.5% of dogs either died, were euthanased or severely worsened in the placebo group compared to 10.8% in the spironolactone group. This represents a 55% reduction in the risk of cardiac morbidity-mortality and a 69% reduction in the risk of cardiac-related death or euthanasia.
Further research2 has also revealed that aldosterone antagonists, such as spironolactone, help to prevent myocardial fibrosis, a pathogenic process involved in the progression of heart failure.
For more information, 'Start Conversation' with Fraser Broadfoot MRCVS at CEVA Animal Health, or ring 01494 781510.
1 Efficacy of spironolactone on survival in dogs with naturally-occurring mitral regurgitation caused by myxomatous mitral value disease. Bernay F, Bland JM, Häggstrőm J, Baduel L, Combes B, Lopez A, Kaltsatos, V. (2010). Journal of Veterinary Internal Medicine.2 Aldosterone receptor antagonists - how cardiovascular actions may explain their beneficial effects in heart failure. Ovaert P, Elliot J, Bernay F, Guillot E, Bardon T. (2010). Journal of Veterinary Pharmacology and Therapeutics.
Two new Postgraduate Deans have been appointed by the Royal College of Veterinary Surgeons to advise and monitor new veterinary surgeons during their Professional Development Phase (PDP), the first stage in veterinary continuing professional development.
Jill Hubbard, a partner at Cibyn Veterinary Surgery, Caernarfon, and organiser of BVA North Wales' young graduate meetings, and Nicky Paull, a former BVA President with extensive experience of running veterinary practices and understanding of the needs of veterinary graduates, were selected from over 40 applicants. They join existing Deans, Professor Agnes Winter and Julian Wells, and replace Professor David Noakes and Stephen Ware, who are retiring from the role having served since 2007, when PDP first became a requirement for veterinary graduates.
Jill Hubbard said: "I have always had a particular interest in how we support and guide our new graduates. This seemed a way of being actively involved - a useful niche to try and fill."
Nicky Paull said: "The development of young veterinary graduates has been of special interest to me for some years. In employing young veterinary surgeons, meeting recent graduates through my political work and the time spent with undergraduates through extra-mural studies and the Society of Practising Veterinary Surgeons' final year student seminars, I'm aware of the need for help and guidance for development of the young vets who are joining our profession."
The PDP applies to every newly qualified veterinary surgeon. It consists of an online record which the vet completes, and which is signed off by a Postgraduate Dean. This helps new vets and their employers check that sufficient experience is being gained so that the vet can progress from the 'Day-One competencies' of a new graduate to those expected of a vet with about a year's in-practice experience.
Vetoquinol has launched a pain monitoring system along similar lines to those used in humans, which can be used by vets and owners to measure pain over time and assess different treatment strategies in dogs.
According to the company, it is widely accepted that all mammals experience pain1and that under treatment is a big issue. Guidelines in treating human pain issued by NICE state that: 'evidence suggests that pain caused by advanced disease remains under-treated'. Veterinary medicine faces a harder task in recognising and treating pain effectively as it relies on behaviour rather than verbal communication.
In human medicine, Client Specific Outcome Measures have been used to assess treatment strategies focussing on identifying the degree of difficulty performing daily tasks on an individual patient to patient basis. Vetoquinol says its pain monitoring system is based on similar principles.
Robert Simpson, Product Manager for Cimalgex said: "The objective assessment of clinical outcomes are a continuing challenge in veterinary medicine; this is particularly true in chronic painful conditions such as osteoarthritis. Use of our Client Specific Outcome Measures form will allow vets and pet owners to more efficiently assess treatment to ensure that the patient is receiving appropriate analgesia.
The form can be adapted to give bespoke outcome measures which are agreed in consultation with the owners. This activity will increase interaction with pet owners and could increase loyalty to the practice; it could also be really useful in geriatric clinics etc as a method of assessing pain outside of consultations in practices."
To find out more or to request a monitoring pad for your practice, contact your Vetoquinol Territory Manager or call 01280 825424.
Benchmark Holdings has announced that it has acquired Improve International limited, the Swindon-based veterinary Continuing Professional Development (CPD) business.
Improve will be added to Benchmark's Technical Publishing division, which provides global knowledge transfer, technical insight, e-learning and market analysis for people and businesses working in agriculture, aquaculture and the food supply chain.
Established in 1998 by a group of veterinary surgeons, Improve organises CPD courses for veterinary professionals across the UK, Republic of Ireland, Scandinavia and mainland Europe from its bases in the UK and Portugal.
Improve's courses are run privately and are accredited by the European School of Veterinary Postgraduate Studies (ESVPS) and/ or Harper Adams University.
In partnership with ESVPS and Harper Adams University, Improve also provides courses and qualifications for Official Veterinarians in England, Scotland and Wales.
Improve's veterinary directors, David Babington (pictured right), Heber Alves and Rui Lobao will all remain with the business.
Benchmark's management says it believes there is considerable scope for online development of the courses within the digital arm of its Technical Publishing division. The division currently offers 15 distance-learning courses, which are tailored to develop core industry skills.
Malcolm Pye, Chief Executive of Benchmark Holdings Plc said: "The acquisition of Improve will enable us to combine our digital and distance learning expertise with Improve's veterinary content across Europe, enhancing our ability to serve the professionals in our key veterinary markets.
"This is a significant step forward for our Technical Publishing division in both of the food and companion animal markets. We plan to take Improve's successful, face-to-face courses and deliver content digitally on an international basis."
The RCVS President and Principal of the RVC, Professor Stuart Reid, has announced that he is to run the London Marathon on 26 April, in aid of the RVC Animal Care Trust, the Veterinary Benevolent Fund (VBF) and Mind.
The RVC Animal Care Trust will use the funds to assist the student bodies at all of the UK veterinary schools. The VBF, through Vetlife, the Vet Helpline and the Veterinary Surgeons' Health Support Programme, offers specific assistance to members of the veterinary team. Mind has been working with the profession and the veterinary schools at all levels in developing approaches to mental health and wellbeing.
Stuart said: "As President of the RCVS and Principal of the RVC I feel that I am in a privileged position and I would like to take every opportunity to help break down the stigma associated with mental health and wellbeing, and to raise what I can to assist these three excellent charities in dealing with what is, sadly, a major issue for us.
"Most of all, I am doing it for the nine people I know personally who are no longer with us, and the many more who have found, and will find, help in time."
If you'd like to help Stuart meet his sponsorship target of £10,000, you can sponsor him at: uk.virginmoneygiving.com/StuartReid.
The pack contains:
For more information, contact your local Dechra equine sales manager.
Researchers from the Waltham Centre for Pet Nutrition have published two studies which reveal, for the first time, the most common bacterial species associated with gum disease in cats.
Working with veterinary dentists and the Harvard affiliated Forsyth Institute, researchers used DNA sequencing technologies to identify 267 bacterial species present in feline dental plaque and build a database detailing the differences between bacterial populations in healthy cats and those in cats with gum disease.
Dr. Ian Davis, Oral Health Researcher at WALTHAM, part of Mars Petcare, said: "This knowledge is a first step in understanding the potential for improving oral health of cats through dietary interventions that target disease-associated bacteria."
The studies also revealed that the bacterial species in feline plaque were more similar to those observed in canine plaque than to those found in humans. This suggests that interventions targeted at bacteria which cause oral disease in humans are unlikely to be effective in cats, and there is more potential to learn from interventions that work well in dogs.
Dr. Davis added: "It’s important for pet owners to know that cats are just as susceptible to gum disease as dogs and understand the importance of maintaining a good oral hygiene routine; ideally including tooth brushing and dental treats or a specific dental diet".
The first study was published in Veterinary Microbiology in February 2015. The second was published on 25th November in PLOS ONE, and can be downloaded here: http://dx.plos.org/10.1371/journal.pone.0136986.
Topics include the pathogenesis of OA, the importance of personalised treatment plans, and practical tips for supporting both pets and caregivers.
The first podcast centres around understanding the pathogenesis of the condition and the importance of thorough clinical examinations, diagnostic imaging and early intervention, all of which can greatly influence long-term outcomes.
Stuart said: “We often see pain as a problem, but it’s also a signal that gives us the opportunity to act early and prevent further progression.
"By the time pain is obvious, the disease is often so advanced that our ability to make a meaningful impact is limited.
"Acting early can change this pattern, and that’s a critical message we need to communicate to pet owners.”
Stuart is joined in the series by Krka’s technical veterinary adviser, Renzo Di Florio.
In subsequent episodes they share their thoughts on the latest advances in osteoarthritis treatment, creating an effective management plan that is individualised for each patient and tips for engaging with caregivers.
Renzo said: “Our goal with this podcast series is to empower veterinary professionals - whether they are new graduates or experienced practitioners - with evidence-based knowledge they can trust and apply.
"We’re excited to share these insights and have more planned for 2025, so stay tuned!”
https://open.spotify.com/show/0uphORU03q29WncwmN2EIa
Hill's Pet Nutrition has announced an average price reduction of over 5 per cent across almost 80 per cent of its product range from 1st March 2010.
The company says this is the first time in its history that such a big price reduction has been implemented, and it comes with a promise that superior nutritional quality won't be compromised.
The price cut comes following market research by Hill's which shows that after one of the deepest recessions in 50 years, more pet owners are becoming cost-conscious, and many are now buying their petfood in the grocery channel or mixing premium foods with economy products.
Another factor in decision-making for some pet owners is the cost per pack, particularly on the larger bag sizes. From April 2010, some Hill's Prescription Diet products will be resized to make them a more affordable purchase. Canine Prescription Diets c/d, d/d, i/d, k/d and j/d will be moved from a 14 Kg bag to a 12 Kg bag. Feline Prescription Diets c/d, k/d, r/d, i/d and s/d will be moved from a 2 Kg bag to a 1.5 kg bag. The price reduction will also be applied proportionately alongside the smaller bag size, so many clients should see a significant reduction at point of purchase. The smaller bags are also easier for practices to store and can increase frequency of client visits providing more opportunities to offer advice and support.
Blake Hawley, Hill's General Manager for UK and Ireland said, "We would like to thank vets, nurses and support staff for their continued support and dedication. Every pet needs and deserves a nutritional assessment and this price reduction will make it easier for vet teams to recommend the best Hill's product, confident those pets are getting high quality nutrition at new, lower prices. Having listened to what the profession had to say in 2009, this year we will demonstrate our commitment to the veterinary profession in very clear and visible ways."
For an up to date price list and support material to assist in communicating the change to clients, please contact your Hill's Territory Manager or call 0800 282438
Virbac has announced the launch of My Virbac, a new website offering a range of business, marketing and technical services for veterinary professionals.
The main elements of My Virbac are:
Virbac Product Manager, Ms Victoria Hudson said: "Virbac was one of the pioneers of the concept of practice support and the services we already offer are highly valued by our customers. In developing My Virbac, we're taking things to a new level. We've worked with business and veterinary experts to develop a practical and helpful range of services which will make a real difference to practices that use them. We plan to add additional services and tools on a regular basis.
"As the veterinary sector becomes increasingly competitive, providing an outstanding clinical service is no longer enough. Practices must also be well-run businesses, with a strong focus on marketing and client retention. Taking advantage of the services and tools available on My Virbac will help practices to ensure they are well placed to succeed even in difficult times."
To access Virbac's services platform, practices and individuals can register at www.my-virbac.co.uk.
Eli Lilly and Company, which owns Elanco Animal Health, has announced an agreement to acquire Novartis Animal Health for approximately $5.4 billion in cash.
Lilly says that on completion of the deal, Elanco will be the second-largest animal health company in terms of global revenue. It will also solidify its number two ranking in the U.S., and improve its position in Europe and the rest of the world.
As part of the agreement, Lilly will acquire Novartis Animal Health's nine manufacturing sites, six dedicated research and development facilities, a global commercial infrastructure with a portfolio of approximately 600 products, a pipeline with more than 40 projects in development, and an experienced team of more than 3,000 employees.
The transaction is expected to be completed by the end of the first quarter of 2015, subject to clearance under the U.S. Hart-Scott-Rodino Antitrust Improvements Act, similar requirements outside the U.S., and other customary closing conditions.
John C. Lechleiter, Ph.D., Lilly's chairman, president and chief executive officer said: "Animal health continues to represent an attractive growth opportunity for Lilly. We intend to keep Elanco and to take advantage of the substantial synergies between our animal health and human health businesses.
"Significant investments in our animal health business in recent years have enabled Elanco to double its revenue since 2008, leading the industry in growth. Global trends suggest continued sustained demand for animal health products in the years ahead. Through this acquisition, which moves Elanco to top-tier in the industry, we intend to create value for our shareholders by adding to our promising pipeline of innovative animal health assets, increasing sales through a larger commercial footprint, and improving efficiencies and lowering costs."
Seven veterinary surgeons who took their final assessments at the University of Liverpool on 6 September have become the first to receive the postgraduate RCVS Certificate in Advanced Veterinary Practice with equine designations.
Dr Mark Holmes, a member of the RCVS sub-committee for the CertAVP who observed the assessments at Liverpool said: "I was very impressed by the quality of all the candidates and the diligence of the examination process.
"It is clear that candidates putting themselves forward for 'named' certificates have demonstrated particular interest in their chosen fields and place considerable value on passing their synoptic examination."
The modular certificates were introduced in 2007 to be a more flexible replacement for the old-style postgraduate certificates. Vets can now choose from 79 subject modules, with RCVS-accredited assessments offered by a range of universities. These institutions may also offer associated courses which vets can take to support their studies, although candidates are free to choose where and how they wish to study.
To build their credits into the full CertAVP qualification candidates must first enrol with the RCVS, which keeps a record of modules achieved. Candidates need to take two compulsory modules, and several of a range of optional modules, within ten years in order to receive the award. Candidates aiming for a designated award must choose specific modules from amongst the options, and additionally pass an overarching 'synoptic' assessment.
For more information about the individual modules and the qualification as a whole, prospective candidates can visit www.rcvs.org.uk/modcerts.
The British Occupational Hygiene Society (BOHS) has announced the publication of a book on controlling skin exposure and wet work. The book aims to fill a knowledge gap about dermal exposure risk management in workplaces which are particularly affected, such as veterinary practices.
The consequences of a failure to adequately control dermal exposure to hazardous agents do not always become apparent until years after exposure, and because of this, many employers are either ignorant of the consequences or ignore the potential for ill-health until it is too late. In Great Britain, over 29,000 people are suffering from work-related skin disease and every year over 3,500 new cases are reported. Alongside this, many workers are unaware of the ways in which skin comes into contact with chemicals, or how dermal exposure can contribute to inadvertent inhalation and ingestion exposure.
Healthcare workers are susceptible. Vets and nurses are, for example, at risk from disinfectants, detergents, wet-work, latex gloves, anaesthetics, antibiotics and antiseptics, phenothiazines, formaldehyde, glutaraldehyde and liquid chloroxylenol.
The book provides an introduction to the structure and functions of the skin, information about the diseases caused by dermal exposure and the occupations and chemicals involved, regulatory requirements related to dermal exposure at work, exposure and risk assessment, and risk management strategies. It is both comprehensive and accessible, and clearly illustrated with photographs, figures and tables throughout, ensuring that it will be of practical use. As a result, BOHS believes that it will make an important contribution to increasing knowledge about control of dermal exposure, and encourage more effective control measures to be introduced in workplaces.
‘Controlling Skin Exposure to Chemicals and Wet-Work' is available for £19.99 and can be purchased on-line via RMS Publishing, www.rmspublishing.co.uk/BOHS.html and Amazon, or by posting/faxing the order form which can be downloaded from the Publications section of the BOHS website.
US veterinary equipment manufacturer Midmark is holding a draw for a Matrx VMS anaesthesia machine, open to all UK veterinary practices.
Click this link, enter your details, and the winner will be announced on 7th July 2010.
Virbac has announced that it is hosting another day of CPD and surfing on Friday 26th April.
During the morning's session, Senior Field Veterinary Advisor Alex Allen BVM&S MRCVS will discuss 'Current thinking on companion animal vaccines', including CaniLeish, Virbac's vaccine for Leishmaniosis. Dermatologist Peri Lau-Gillard DrMedVet CertVD DipECVD MRCVS will then talk on 'Awful Atopics.'
The venue is the Atlantic Hotel, Newquay (close to Fistral Beach), with delegates transported to the nearby Surf School after lunch for their surfing lesson. A buffet lunch and post-surfing drinks will be provided by Virbac.
Territory manager and organiser Della Tomlinson said: "After last year's event we have had requests to repeat it from as far afield as London and Edinburgh, and we think that £30 for 3 hours of quality CPD is great value. As well as the obvious fun element of the surfing, we're deliberately holding the event on a Friday so vets can take advantage and enjoy a well-earned weekend away at a great location. Sadly this will have to be at your own expense!"
For more information or to book a place please contact Claire Lewis on 01359 243228 or claire.lewis@virbac.co.uk.
322 farmers took part in the survey, 83% of which had a flock of over 100 ewes.
Three quarters of them had experienced abortions in their ewes during both the 2018/2019 and 2019/2020 lambing seasons. Of those that experienced abortions during the 2019/2020 lambing season, a quarter reported that the problem occurred in more than 2% of their flock and 44% of them did not ask their vet to investigate.
Katherine Timms, Ceva Animal Health’s ruminant veterinary advisor said: “Farmers who decide not to investigate why their ewes are aborting may well experience an abortion storm during the following year’s lambing season as Chlamydophila abortus, the bacteria that causes EAE, has the ability to lay latent in ewes until the next pregnancy.
“This means that one infected sheep shedding at lambing has the potential to infect multiple ewes that will almost certainly abort at their next lambing. The consequences can be financially and reproductively devastating for farmers and it’s advisable that vets raise awareness of EAE testing with their clients to help prevent this from happening. Ceva’s Assure Ewe programme offers farmers subsidised farm serology testing for Chlamydia abortus. Aborted ewes can be tested for Chlamydia abortus, ideally from three weeks to three months after lambing.”
Of the 47% of farmers that are not vaccinating against EAE, 57% said they would consider it. Reasons not to vaccinate included farmers believing that they had closed flocks (59%) and EAE not having been diagnosed (57%). Only 20% decided not to vaccinate because of cost and 25% because they did not feel it was worthwhile.
Ceva is continuing its ‘For Flock’s Sake – Vaccinate!’ initiative during 2021 to help raise awareness of EAE and highlight the importance of vaccination. This year, Ceva is also highlighting the importance of testing aborted ewes through its ‘For Flock’s Sake Get Tested’ campaign which encourages the submission of samples to a diagnostic laboratory or blood sampling after lambing has finished.
For more information, visit www.enzooticabortion.co.uk, contact your Ceva Animal Health account manager, call Ceva on 01494 781510 or email cevauk@ceva.com.
Reference
Photo: Ewe ewe looking at?